Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01015274 · ClinicalTrials.gov registry record
Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients
A clinical trial, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- 10
- Enrollment target
NCT01015274 is a clinical trial that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 10 participants.
The verdict
NCT01015274 has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The long-term objective of this research is to develop a non-invasive approach for early assessment of which patients are at high risk for future development of skeletal muscle atrophy. The investigators hypothesize that the rate constant for the terminal portion of the isotope decay curve following ingestion of a single oral dose of deuterated-3-methylhistidine (D-3MH) provides an accurate measure of this increased risk and that this rate constant can be measured non-invasively from timed spot urine samples.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2009-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01015274
The ClinicalTrials.gov registry entry for NCT01015274 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01015274 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01015274 about?
NCT01015274 is a clinical study titled "Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients". The long-term objective of this research is to develop a non-invasive approach for early assessment of which patients are at high risk for future development of skeletal muscle atrophy. The investigators hypothesize that the rate constant for the terminal portion of the isotope decay curve following...
What is the current status of trial NCT01015274?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2009-10.
Who is sponsoring clinical trial NCT01015274?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.